Article Details
Retrieved on: 2024-04-09 15:35:37
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the emergence of two biotech companies, Seaport Therapeutics and Nvelop Therapeutics, with substantial funding and novel technologies in neuropsychiatric medicine and genetic therapy delivery, involving industry veterans like Daphne Zohar and partnerships with Sofinnova and Atlas Venture.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here